MedPath

Adapting effective mHealth interventions to improve uptake and adherence of the HIV pre-exposure prophylaxis (PrEP) in Thai young Men who have Sex with Me

Phase 2
Conditions
HIV-uninfected young MSM at risk for acquiring HIV infection, ages 16 to 29 years.
HIV, technology-based intervention to promote both motivation to begin PrEP,
HIV pre-exposure prophylaxis (PrEP) in Thai young MSM
Registration Number
TCTR20210916003
Lead Sponsor
Institute of HIV Research and Innovation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
Male
Target Recruitment
170
Inclusion Criteria

1) age 16-29 years
2) men who report sex with men in the past 12 months
3) laboratory confirmed HIV negative status
4) self-reported evidence of being at-risk for HIV acquisition, including one of the following in the past 6 months: having a sex with an HIV-positive partner, having anal sex without using a condom, being diagnosed with an STI, or having any illicit drug use (e.g., Amphetamine type stimulants)
5) able to understand, read and speak Thai
6) either having not started PrEP (Group 1: PrEP naive) or currently on PrEP but not adherent to PrEP (taking 3 pills/week) in the past month (Group 2: PrEP users)

Exclusion Criteria

1) in a mutually monogamous relationship of > 6 months with a partner who recently tested HIV-negative
2) a serious cognitive or psychiatric problem that would compromise ability to provide informed consent
3) currently enrolled in another HIV intervention study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
MES-PrEP and MTM 12 months Eligibility is the same for both Aim 1 and Aim 2 phases of the study.
Secondary Outcome Measures
NameTimeMethod
/A N/A N/A
© Copyright 2025. All Rights Reserved by MedPath